Apresoline and Atacand drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Apresoline (hydralazine hydrochloride) and Atacand (candesartan cilexetil). Common drug interactions include disease recurrence among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Apresoline and Atacand. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Apresoline?
Apresoline has active ingredients of hydralazine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,475 Apresoline users. Check the latest studies of Apresoline.
What is Atacand?
Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
23 people who take Apresoline and Atacand together, and have interactions are studied.

What are the common drug interactions of Apresoline and Atacand, by gender? *:
female:
- Disease recurrence
- Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
- Electrocardiogram qt prolonged
- Family stress
- Hyperglycaemia (high blood sugar)
- Hypersensitivity
- Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
- Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
- Procedural haemorrhage (procedural bleeding)
- Pulmonary embolism (blockage of the main artery of the lung)
male:
- Drug ineffective
- Acute stress disorder
- Cerebral small vessel ischaemic disease (inadequate blood supply to small blood vessel of brain)
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Confusional state
- Depression
- Disturbance in attention
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Fall
- Fatigue (feeling of tiredness)
What are the common drug interactions of Apresoline and Atacand, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Social problem
- Spinal osteoarthritis (joint cartilage loss in spine)
- Spondylitis (an inflammation of the vertebra with spinal cord involvement)
- Suicidal ideation
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Acute stress disorder
- Adjustment disorder
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anxiety
- Back pain
50-59:
- Blood glucose increased
- Fatigue (feeling of tiredness)
- Pneumonia
- Staphylococcal infection (an infection with staphylococcus bacteria)
60+:
- Blood pressure diastolic decreased
- Lower respiratory tract infection
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Blood pressure systolic increased
- Contusion (a type of hematoma of tissue in which capillaries)
- Cystitis (inflammation of the wall of the bladder)
- Haemophilus infection (bacterial infection by haemophilus influenzae)
- Haemorrhage (bleeding)
- Hip fracture
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
What are the existing conditions these people have? *
- Asthma: 8 people, 34.78%
- Diabetes: 4 people, 17.39%
- Pain: 3 people, 13.04%
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 8.70%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 8.70%
- Pulmonary Congestion (congestion in the lungs): 2 people, 8.70%
- Neuropathy Peripheral (surface nerve damage): 2 people, 8.70%
- Nausea And Vomiting: 2 people, 8.70%
- Nausea (feeling of having an urge to vomit): 2 people, 8.70%
- Insomnia (sleeplessness): 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Apresoline and Atacand?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Apresoline (2,475 reports)
- Atacand (22,473 reports)
Browse all drug interactions of Apresoline and Atacand:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Apresoline:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Atacand:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Apresoline and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Atacand and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on hydralazine hydrochloride and candesartan cilexetil (the active ingredients of Apresoline and Atacand, respectively), and Apresoline and Atacand (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Scar and Rashes - 6 seconds ago
- Rosacea and Abdominal Pain - 6 seconds ago
- Could Combipatch cause Hypercholesterolaemia Aggravated? - 7 seconds ago
- Drug interactions of Tylenol W/ Codeine No. 3 and Ativan - 9 seconds ago
- Could Leflunomide cause Status Epilepticus? - 9 seconds ago
- Could Monopril cause Gastric Ulcer? - 9 seconds ago
- Could Januvia cause Cytokine Release Syndrome? - 10 seconds ago
- Could Prolia cause Tooth Resorption? - 10 seconds ago
- Respiratory Acidosis and Hyperkalemia - 16 seconds ago
- Could Sulfamethoxazole cause Upper Limb Fracture? - 16 seconds ago